Printer Friendly

Just Released: "Auspex Pharmaceuticals, Inc. - Product Pipeline Review - 2013".

[ClickPress, Fri Jun 28 2013] Global Market Direct's pharmaceuticals report, "Auspex Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Auspex Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Auspex Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Auspex Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at

- http://www.fastmr.com/prod/618537_auspex_pharmaceuticals_inc_product_pipeline.aspx?afid=301

Scope

* Auspex Pharmaceuticals, Inc. - Brief Auspex Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.

* Review of current pipeline of Auspex Pharmaceuticals, Inc. human therapeutic division.

* Overview of pipeline therapeutics across various therapy areas.

* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

* Product profiles for late stage and clinical stage products of Auspex Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

* Recent updates of the Auspex Pharmaceuticals, Inc.'s pipeline in the last quarter.

* Key discontinued and dormant projects.

* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate Auspex Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.

* Assess the growth potential of Auspex Pharmaceuticals, Inc. in its therapy areas of focus.

* Identify new drug targets and therapeutic classes in the Auspex Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

* Exploit collaboration and partnership opportunities with Auspex Pharmaceuticals, Inc..

* Avoid Intellectual Property Rights related issues.

* Explore the dormant and discontinued projects of Auspex Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Auspex Pharmaceuticals, Inc.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- AVEO Pharmaceuticals, Inc. - Product Pipeline Review - 2013

- Inflammatory Bowel Disease - Pipeline Review, H1 2013

Copyright 2013 ClickPress

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2013 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:ClickPress
Date:Jun 28, 2013
Words:463
Previous Article:Report Published: "Mimetogen Pharmaceuticals Inc. - Product Pipeline Review - 2013".
Next Article:Recently released market study: Czech Republic Metals Report Q3 2013.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters